Diabetes & Metabolism

Article	Citations
Efficacy and safety of once-weekly semaglutide 1.0 mg vs once-daily liraglutide 1.2 mg as add-on to 1–3 oral antidiabetic drugs in subjects with type 2 diabetes (SUSTAIN 10)	203
Metformin and COVID-19: From cellular mechanisms to reduced mortality	129
Patients with diabetes are at higher risk for severe illness from COVID-19	115
Prognostic factors in patients with diabetes hospitalized for COVID-19: Findings from the CORONADO study and other recent reports	105
Body mass index and outcome in patients with COVID-19: A dose–response meta-analysis	97
Negative impact of hyperglycaemia on tocilizumab therapy in Covid-19 patients	84
NAFLD, and cardiovascular and cardiac diseases: Factors influencing risk, prediction and treatment	77
Efficacy and safety of anti-hyperglycaemic drugs in patients with non-alcoholic fatty liver disease with or without diabetes: An updated systematic review of randomized controlled trials	75
Potential metabolic and inflammatory pathways between COVID-19 and new-onset diabetes	68
Socioeconomic inequalities and type 2 diabetes complications: A systematic review	66
Routine use of statins and increased COVID-19 related mortality in inpatients with type 2 diabetes: Results from the CORONADO study	55
Trimethylamine N-oxide levels are associated with NASH in obese subjects with type 2 diabetes	55
A systematic review of nudge theories and strategies used to influence adult health behaviour and outcome in diabetes management	53
Metformin use is associated with a reduced risk of mortality in patients with diabetes hospitalised for COVID-19	52
Cardiovascular disease in type 1 diabetes: A review of epidemiological data and underlying mechanisms	52
Effects of COVID-19 pandemic lockdown on gestational diabetes mellitus: A retrospective study	50
Screening for non-alcoholic fatty liver disease using liver stiffness measurement and its association with chronic kidney disease and cardiovascular complications in patients with type 2 diabetes	45
Effects of 12-week treatment with dapagliflozin and gliclazide on faecal microbiome: Results of a double-blind randomized trial in patients with type 2 diabetes	41
Meat and fish intake and type 2 diabetes: Dose–response meta-analysis of prospective cohort studies	39
Elevated triglyceride–glucose index predicts risk of incident ischaemic stroke: The Rural Chinese cohort study	38
Is the type 2 diabetes epidemic plateauing in France? A nationwide population-based study	32
Glucose variability and diabetes complications: Risk factor or biomarker? Can we disentangle the “Gordian Knot”?	32
Adiponectin to leptin ratio reflects inflammatory burden and survival in COVID-19	32
Statins and clinical outcomes with COVID-19: Meta-analyses of observational studies	32
DPP-4 inhibition and COVID-19: From initial concerns to recent expectations	29

Fulminant type 1 diabetes after COVID-19 vaccination	29
Smoking and diabetes interplay: A comprehensive review and joint statement	28
Detrimental effects of metabolic dysfunction-associated fatty liver disease and increased neutrophil-to-lymphocyte ratio on severity of COVID-19	27
Regulation of hepatokine gene expression in response to fasting and feeding: Influence of PPAR-α and insulin-dependent signalling in hepatocytes	27
Associations between specific plasma ceramides and severity of coronary-artery stenosis assessed by coronary angiography	26
Impact of diabetes mellitus on mortality rates and outcomes in myocardial infarction	25
Reduction in HbA1c with SGLT2 inhibitors vs. DPP-4 inhibitors as add-ons to metformin monotherapy according to baseline HbA1c: A systematic review of randomized controlled trials	25
The obesity treatment dilemma: Why dieting is both the answer and the problem? A mechanistic overview	24
Association between increased plasma ceramides and chronic kidney disease in patients with and without ischemic heart disease	24
Liraglutide and sitagliptin have no effect on intestinal microbiota composition: A 12-week randomized placebo-controlled trial in adults with type 2 diabetes	24
Diabetes mellitus in the era of climate change	24
Diabetic ketoacidosis and mortality in COVID-19 infection	23
Higher liver stiffness scores are associated with early kidney dysfunction in patients with histologically proven non-cirrhotic NAFLD	22
Targeting ageing and preventing organ degeneration with metformin	22
Circulating retinol-binding protein 4 is associated with the development and regression of non-alcoholic fatty liver disease	22
The gut microbiota and diabetic cardiomyopathy in humans	21
Triglyceride–glucose index associates with incident heart failure: A cohort study	20
Practical implementation of automated closed-loop insulin delivery: A French position statement	20
The association between gestational diabetes mellitus and cancer in women: A systematic review and meta-analysis of observational studies	20
Risk stratification and screening for coronary artery disease in asymptomatic patients with diabetes mellitus: Position paper of the French Society of Cardiology and the French-speaking Society of Dia	20
Eye disorders other than diabetic retinopathy in patients with diabetes	19
COVID-19 symptoms masking inaugural ketoacidosis of type 1 diabetes	18
Management of diabetes mellitus in patients with cirrhosis: An overview and joint statement	18
Sarcopenia is associated with non-alcoholic fatty liver disease in men with type 2 diabetes	18
Is there an association between metformin use and clinical outcomes in diabetes patients with COVID-19?	18
Glycaemic control and hypoglycaemia risk with insulin glargine 300 U/mL versus glargine 100 U/mL: A patient-level meta-analysis examining older and younger adults with type 2 diabetes	18
Exposure to persistent organic pollutants and the risk of type 2 diabetes: a case-cohort study	18
Cardiovascular risks of periodontitis and oral hygiene indicators in patients with diabetes mellitus	17
Lower limb amputations: protection with GLP-1 receptor agonists rather than increased risk with SGLT2 inhibitors?	17
The diuretic effects of SGLT2 inhibitors: A comprehensive review of their specificities and their role in renal protection	17
SGLT2 inhibitors and the autonomic nervous system in diabetes: A promising challenge to better understand multiple target improvement	17
Associations of serum magnesium levels and calcium–magnesium ratios with mortality in patients with coronary artery disease	16
Determinants of aspirin resistance in patients with type 2 diabetes	16
Three alternative ways to screen for hyperglycaemia in pregnancy during the COVID-19 pandemic	16
Gestational diabetes is associated with SARS-CoV-2 infection during pregnancy: A case-control study	15
Lean non-alcoholic fatty liver disease and risk of incident diabetes in a euglycaemic population undergoing health check-ups: A cohort study	15
Sodium–glucose cotransporter-2 inhibitors for diabetic kidney disease: Targeting Warburg effects in proximal tubular cells	15
Five-year mortality in patients with diabetic foot ulcer during 2009–2010 was lower than expected	15
Serum uric acid in early pregnancy and risk of gestational diabetes mellitus: A cohort study of 85,609 pregnant women	15
Euglycaemic ketoacidosis during gestational diabetes with concomitant COVID-19 infection	15
Metabolic dysfunction-associated fatty liver disease and risk of incident chronic kidney disease: A nationwide cohort study	15
SGLT2 inhibition during the COVID-19 epidemic: Friend or foe?	15
Insulin sensitivity improvement with exercise training is mediated by body weight loss in subjects with metabolic syndrome	14
Fasting and post-oral-glucose-load levels of methylglyoxal are associated with microvascular, but not macrovascular, disease in individuals with and without (pre)diabetes: The Maastricht Study	14
Association of hyperglycaemia with hospital mortality in nondiabetic COVID-19 patients: A cohort study	14
Lower trabecular bone score in type 2 diabetes mellitus: A role for fat mass and insulin resistance beyond hyperglycaemia	14
Risk of sepsis and pneumonia in patients initiated on SGLT2 inhibitors and DPP-4 inhibitors	14
Performance of a selective screening strategy for diagnosis of hyperglycaemia in pregnancy as defined by IADPSG/WHO criteria	14
The triglycerides and glucose (TyG) index: A new marker associated with nonalcoholic steatohepatitis (NASH) in obese patients	14
Effect of high-dose mineralocorticoid receptor antagonist eplerenone on urinary albumin excretion in patients with type 2 diabetes and high cardiovascular risk: Data from the MIRAD trial	14

Predictors of type 2 diabetes relapse after Roux-en-Y Gastric Bypass: A ten-year follow-up study	14
Disagreement between capillary blood glucose and flash glucose monitoring sensor can lead to inadequate treatment adjustments during pregnancy	14
Challenging 2019 ESC guidelines for the management of type 2 diabetes	14
Association of diabetes and outcomes in patients with COVID-19: Propensity score-matched analyses from a French retrospective cohort	13
Antidiabetic agents and risk of atrial fibrillation/flutter: A comparative critical analysis with a focus on differences between SGLT2 inhibitors and GLP-1 receptor agonists	13
Dietary sodium and potassium and risk of diabetes: A prospective study using data from the China Health and Nutrition Survey	12
Efficacy / safety balance of DPP-4 inhibitors versus SGLT2 inhibitors in elderly patients with type 2 diabetes	12
Fasting plasma glucose variability in midlife and risk of Parkinson's disease: A nationwide population-based study	12
Association between sodium glucose co-transporter 2 inhibitors and incident glaucoma in patients with type 2 diabetes: A multi-institutional cohort study in Taiwan	12
Association between sleep duration in early pregnancy and risk of gestational diabetes mellitus: a prospective cohort study	12
Protection by metformin against severe Covid-19: An in-depth mechanistic analysis	12
A high lean body mass is not protecting from type 2 diabetes in the presence of a high body fat mass	12
SGLT2 inhibition increases serum copeptin in young adults with type 1 diabetes	12
Bidirectional relationship between diabetes and pulmonary function: a systematic review and meta-analysis	12
Canagliflozin could improve the levels of renal oxygenation in newly diagnosed type 2 diabetes patients with normal renal function	11
Glycaemic control for painful diabetic peripheral neuropathy is more than fasting plasma glucose and glycated haemoglobin	11
Prevalence and predictors of non-alcoholic steatohepatitis in subjects with morbid obesity and with or without type 2 diabetes	11
Prognosis associated with initial care of increased fasting glucose in early pregnancy: A retrospective study	11
Liraglutide 3 mg as a weight-loss strategy after failed bariatric surgery in a patient with hypothalamic obesity following craniopharyngioma	10
Acute renal injury events in diabetic patients treated with SGLT2 inhibitors: A comprehensive review with a special reference to RAAS blockers	10
Impact of gender on relative rates of cardiovascular events in patients with diabetes	10
Efficacy of semaglutide versus liraglutide in clinical practice	10
Gender and age differences in the association between sleep characteristics and fasting glucose levels in Chinese adults	9
Glucagon-like peptide-1 receptor agonists or sodium–glucose cotransporter-2 inhibitors as add-on therapy for patients with type 2 diabetes? A systematic review and meta-analysis of surrogate metabolic	9
Insulin secretion and sensitivity before and after surgical treatment for aldosterone-producing adenoma	9
Effects of remote care of patients with poorly controlled type 1 diabetes included in an experimental telemonitoring programme	9
Glycaemic variabilities: Key questions in pursuit of clarity	9
Efficacy and safety profile of SGLT2 inhibitors in the elderly: How is the benefit/risk balance?	9
Dose–response relationship between serum fibroblast growth factor 21 and liver fat content in non-alcoholic fatty liver disease	9
Is there a residual risk of large-for-gestational-age infant related to gestational diabetes mellitus when it is treated?	8
Metformin treatment is associated with an increase in bone mineral density in type 2 diabetes mellitus patients in China: A retrospective single center study	8
Glyburide therapy for gestational diabetes: Glycaemic control, maternal hypoglycaemia, and treatment failure	8
Distinct uric acid trajectories are associated with incident diabetes in an overweight Chinese population	8
Associations between serum total, free and bioavailable testosterone and non-alcoholic fatty liver disease in community-dwelling middle-aged and elderly women	8
Immune checkpoint inhibitors and diabetes: Mechanisms and predictors	8
Sleep duration and mortality in patients with diabetes: Results from the 2007–2015 Korea national health and nutrition examination survey	7
Circulating omega-7 fatty acids are differentially related to metabolic dysfunction and incident type II diabetes: The Multi-Ethnic Study of Atherosclerosis (MESA)	7
Towards individualised and optimalised positioning of non-ventilated COVID-19 patients: Putting the affected parts of the lung(s) on top?	7
Significant association between blood lead (Pb) level and haemoglobin A1c in non-diabetic population	7
SGLT2i as fourth-line therapy and risk of mortality, end-stage renal diseases and cardiovascular diseases in patients with type 2 diabetes mellitus	7
Metabolic characteristics and adverse pregnancy outcomes for women with hyperglycaemia in pregnancy as a function of insulin resistance	7
Association between specific plasma ceramides and high-sensitivity C-reactive protein levels in postmenopausal women with type 2 diabetes	7
Whole-exome sequencing identifies the first French MODY 6 family with a new mutation in the NEUROD1 gene	7
Objective and subjective sleep measures are associated with HbA1c and insulin sensitivity in the general population: Findings from the ORISCAV-LUX-2 study	7
Use of DPP4i reduced odds of clinical deterioration and hyperinflammatory syndrome in COVID-19 patients with type 2 diabetes: Propensity score analysis of a territory-wide cohort in Hong Kong	7
Efficacy and safety of enavogliflozin versus dapagliflozin added to metformin plus gemigliptin treatment in patients with type 2 diabetes: A double-blind, randomized, comparator-active study: ENHANCE-	7
Transitions in metabolic health status over time and risk of heart failure: A prospective study	7
Patient-reported outcome measures (PROMs) and patient-reported experience measures (PREMs), it's time to give more credits to patients’ voice in research: the example of assessing hypoglycemia burden	7
Effects of H1-Antihistamines on hepatocellular carcinoma risk in patients with type 2 diabetes mellitus	7
Application of medium-term metrics for assessing glucose homoeostasis: Usefulness, strengths and weaknesses	6
Liraglutide reduces plasma PCSK9 in patients with type 2 diabetes not treated with statins	6
Glucose-lowering agents and risk of ventricular arrhythmias and sudden cardiac death: A comprehensive review ranging from sulphonylureas to SGLT2 inhibitors	6
Variability in clinical presentation of diabetes mellitus during anti-PD-1 immunotherapy	6
Early life Bacillus Calmette-Guerin vaccination and incidence of type 1, type 2, and latent autoimmune diabetes in adulthood	6
Prevalence and risk of diabetic complications in young-onset versus late-onset type 2 diabetes mellitus	6
The association between metformin treatment and COVID-19 outcomes according to metformin continuation during hospitalisation	6
Effect of glucagon-like peptide 1 receptor agonists on the renal protection in patients with type 2 diabetes: A systematic review and meta-analysis	6
Associations of young onset age and genetic risk of beta cell dysfunction with glycaemic progression in individuals with type 2 diabetes	6
Dapagliflozin increases retinal thickness in type 2 diabetic patients as compared with glibenclamide: A randomized controlled trial	6
Plasma level of ATPase inhibitory factor 1 (IF1) is associated with type 2 diabetes risk in humans: A prospective cohort study	6
Empagliflozin cardiovascular and renal effectiveness and safety compared to dipeptidyl peptidase-4 inhibitors across 11 countries in Europe and Asia: Results from the EMPagliflozin compaRative effectI	6
Overweight and risk of type 2 diabetes: A prospective Chinese twin study	5
Increased circulating cell-free DNA in insulin resistance	5
The impact of canagliflozin on the risk of neuropathy events: A post-hoc exploratory analysis of the CREDENCE trial	5
A low-carbohydrate high-fat diet initiated promptly after diagnosis provides clinical remission in three patients with type 1 diabetes	5
Cardiac arrhythmias and electrophysiologic responses during spontaneous hyperglycaemia in adults with type 1 diabetes mellitus	5
Lipoatrophic diabetes in familial partial lipodystrophy type 2: From insulin resistance to diabetes	5
Number Needed-to-Treat (NNT): Is it a necessary marker of therapeutic efficiency?	5
Musculoskeletal disorders in patients with type 1 diabetes: An understudied group of diabetes complications that deserves further investigation	5
PNPLA3 polymorphism influences the association between high-normal TSH level and NASH in euthyroid adults with biopsy-proven NAFLD	5
Residual risk associations between initial hyperglycemia and adverse pregnancy outcomes in a large cohort including 6709 women with gestational diabetes	5
Factors associated with pneumococcal vaccination in 2040 people with type 2 diabetes: A cross-sectional study	5
High Intensity Interval Training reduces hypoglycemic events compared with continuous aerobic training in individuals with type 1 diabetes	5
Influence of sexual orientation on diabetes management in US adults with diabetes	5
Cardioprotective effects of dipeptidyl peptidase-4 inhibitors versus sulfonylureas in addition to metformin: A nationwide cohort study of patients with type 2 diabetes	5
Healing of diabetic foot ulcers is independently associated with the use of angiotensin receptor blockers but not with those of diuretics and angiotensin conversion enzyme inhibitors	5
Diabetes is not associated with COVID-19-related mortality in older institutionalized people	5
Remission of necrobiosis lipoidica diabeticorum with a JAK1/2 inhibitor: A case report	5
Cross-talk between non-alcoholic fatty liver disease and cardiovascular disease: implications for future trial design	5
Roux-en-Y gastric bypass, but not sleeve gastrectomy, decreases plasma PCSK9 levels in morbidly obese patients	5

Associations of visit-to-visit fasting glucose with risk of mortality: A retrospective cohort study of 48,077 people with type 2 diabetes	5
Postprandial glucose is correlated with an increasing risk of liver fibrosis in Chinese patients with nonalcoholic fatty liver disease	5
Marked elevation of plasma procalcitonin levels in patients with diabetic ketoacidosis: A possible useful diagnostic biomarker	5
Real world evidence of the efficacy of two hybrid closed loop systems for children and adults with type 1 diabetes with some clinical warnings	5
Heart failure hospitalisation relative to major atherosclerotic events in type 2 diabetes with versus without chronic kidney disease: A meta-analysis of cardiovascular outcomes trials	5
Could metformin modulate cardiovascular outcomes differently with DPP-4 inhibitors compared with SGLT2 inhibitors?	5
Concise review of lipidomics in nonalcoholic fatty liver disease	5
Do GLP-1RAs and SGLT-2is reduce cardiovascular events in women with type 2 diabetes? A systematic review and meta-analysis	5
Lifestyle changes in patients with morbid obesity and type 2 diabetes mellitus during the COVID-19 pandemic	5
Patients with type 1 diabetes in a tertiary setting do not attain recommended lipid targets	5
Retinopathy as an independent predictor of all-cause mortality in individuals with type 2 diabetes	5
Comparison of efficacy and safety of empagliflozin vs linagliptin added to premixed insulin in patients with uncontrolled type 2 diabetes: A randomized, open-label study	4
Diabetic retinopathy in well-controlled type 2 diabetes: Role of glycaemic memory	4
Screening strategies for glucose tolerance abnormalities and diabetes in people with cystic fibrosis	4
MG53 marks poor beta cell performance and predicts onset of type 2 diabetes in subjects with different degrees of glucose tolerance.	4
Calibration free continuous glucose monitoring (CGM) devices: Weighing up the benefits and limitations	4
Pancreas allograft rejection occurring after ChAdOx1 nCoV-19 vaccine	4
Lipoprotein(a) levels are doubled in left-handed patients with diabetes	4
Type 1 diabetes mellitus and risks of major psychiatric disorders: A nationwide population-based cohort study	4
Competing risk analysis on visit-to-visit glucose variations and risk of depression: The Taiwan Diabetes Study	4
Association of treatment-achieved HbA1c with incidence of coronary artery disease and severe eye disease in diabetes patients	4
Pancreatic and gut hormone responses to mixed meal test in post-chronic pancreatitis diabetes mellitus	4
Pumps that predict and manage low blood glucose are superior to pumps with stand-alone CGM for reducing hypoglycaemia in type 1 diabetes patients in a real-world setting	4
HbA1c at the time of testing for gestational diabetes identifies women at risk for pregnancy complications	4
Serum fructosamine predicts macrosomia in well-controlled hyperglycaemic pregnant women: An observational cross-sectional study	4
Pregnant type 1 diabetes women with rises in C-peptide display higher levels of regulatory T cells: A pilot study	4
Fulminant type 1 diabetes: Report of a new French Caucasian case and recent findings	4
Statistical and clinical significances: Are they equivalent?	3
Fasting serum copeptin and asymptomatic peripheral artery disease: No association in patients with type 1 diabetes mellitus	3
Compared impact of diabetes on the risk of heart failure from acute myocardial infarction to chronic coronary artery disease	3
Clinical relevance of coronary risk classification and reclassification with coronary artery calcium score in asymptomatic people living with diabetes. An observational study	3
Age-related difference in the impact of diabetes mellitus on all-cause mortality after acute myocardial infarction	3
Anaemia and its risk factors and association with treatments in patients with diabetes: A cross-sectional study	3
Lung function as a predictor of incident type 2 diabetes in community-dwelling adults: A longitudinal finding over 12 years from the Korean Genome and Epidemiology Study	3
Fewer Type A personality traits in type 2 diabetes patients with diabetic foot ulcer	3
Treatment of women with mild gestational diabetes mellitus decreases the risk of adverse perinatal outcomes	3
Exercise reduces the risk of chronic kidney disease in individuals with nonalcoholic fatty liver disease: A nationwide cohort study	3
Current status of insulin degludec in type 1 and type 2 diabetes based on randomized and observational trials	3
Indispensable but deceptive evidence-based medicine	3
Leisure-time physical activity and mortality risk in type 2 diabetes: A nationwide cohort study	3
Increased mortality risk associated with statins in the CORONADO study	3
Do SGLT2 inhibitors and GLP-1 receptor agonists modulate differently the risk of stroke ? Discordance between randomised controlled trials and observational studies	3
Incretin response in immune checkpoint inhibitor-induced diabetes: an observational study	3
High frequency of transaminase elevation following diabetic ketoacidosis	3